Embrace the next era of drug discovery with PhaSER's revolutionary 8HUM Mouse Model. Unlock significant time, resource, and cost savings, propelling the swift delivery of innovative drugs to market. Join us in reshaping the landscape of pharmaceutical advancement.
PhaSER is transforming the landscape of drug discovery through the introduction of the 8HUM Mouse Model, a groundbreaking advancement in creating a more human-like model for drug development. In response to the limitations posed by traditional animal models in studying drug efficacy, we have developed a mouse model that addresses these challenges and closely replicates human drug metabolism.
Phaser has a team of experts involved in drug discovery, development, and clinical trials.
• We can supply 8HUM mice or subcellular fractions, e.g. microsomes
• We can supply detailed information on the characteristics of the 8HUM model.
• We can discuss drug development projects and how 8HUM can contribute to a program of work at all levels.
Company Details
- Employees
- 2
- Founded
- 2022
- Address
- Dundee, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.phaserbio.com/
- HQ
- Dundee
Phaser Biomedical Questions
Phaser Biomedical's website is https://www.phaserbio.com/
Phaser Biomedical's LinkedIn profile is https://uk.linkedin.com/company/phaser-biomedical
Phaser Biomedical has
2 employees.
View email and phone details for 2
employees at Phaser Biomedical.
Phaser Biomedical's industry is
Biotechnology Research
Phaser Biomedical's top competitors are
Nexabiome,
Life Science Group Ltd.,
Open & Candid,
Alveogene,
Harness Therapeutics,
Envol Biomedical,
Ufraction8,
Bioliberty,
Prothea Technologies,
Network.
Phaser Biomedical's categories are Biotechnology Research
Phaser Biomedical's founding year is 2022
